Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
443.1 USD | +0.56% | +4.82% | +8.92% |
05-15 | Vertex Pharmaceuticals Incorporated Appoints Jennifer Schneider as Independent Director | CI |
05-14 | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.92% | 114B | |
+11.34% | 104B | |
-12.85% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-2.46% | 17.89B | |
+8.11% | 14.28B | |
+34.89% | 12.55B | |
-24.33% | 8.45B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated, Q4 2023 Earnings Call, Feb 05, 2024